Alzheimer’s disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually even the ability to carry out the simplest tasks of daily living. Approximately 500,000 people die each year who have Alzheimer’s. Plaques and tangles in the brain are two of the main features of Alzheimer’s disease. This is followed by the loss of connections between neurons in the brain. Currently only symptomatic treatments exist. Recent clinical trials demonstrated that development of new anti-Aβ antibodies is necessary to provide clinical benefits to AD patients.